Key Insights

Highlights

Treatment Research

3 treatments under study, led by Online Educational Materials

Research Leaders

6 sponsors active, led by M.D. Anderson Cancer Center

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Suspended1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07787156Not ApplicableRecruiting

Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial

NCT06870916SuspendedPrimary

Supporting Informed Decision Making About Multi-cancer Early Detection Testing

Showing all 2 trials

Research Network

Common Treatments

  • Online Educational Materials1
  • Multicancer Early Detection1
  • Telephone Education Session1

Active Sponsors

  • M.D. Anderson Cancer Center1
  • Brigham and Women's Hospital1
  • Exact Science Corporation1
  • Pancreatic Cancer Action Network1
  • Dana-Farber Cancer Institute1

Top Investigators

Related Conditions

  • Family History Of Pancreas Cancer1
  • Genetic Testing1
  • Pancreatic Ductal Adenocarcinoma Pdac1

Activity Timeline